IKZF2通过Akt1/SIRT1信号途径调控银屑病中CD4+CD25highFOXP3+Treg细胞稳定性的研究
批准号:
81371729
项目类别:
面上项目
资助金额:
70.0 万元
负责人:
陈凌
依托单位:
学科分类:
皮肤免疫性疾病
结题年份:
2017
批准年份:
2013
项目状态:
已结题
项目参与者:
Philip N· Tsichlis、Changchuin Mao、李平、杨亚东、杨晓鲲、徐巧瑜、杨涛
中文摘要
CD4+CD25highFOXP3+Treg细胞(Tri-Treg)抑制功能下降,导致效应性T细胞过度活化是银屑病免疫学紊乱的重要环节。我们证明,银屑病中Tri-Treg细胞不稳定,在链球菌等感染下通过mTORC2-Akt1轴的活化可失去FOXP3,转变为效应性T细胞。同时发现,IKZF2+ Tri-Treg亚群稳定性强,但机制不清。去乙酰化酶SIRT1降低FOXP3乙酰化,通过核浆转运调控其稳定性。结合前期基础,我们提出IKZF2通过抑制Akt1亚型活化来调节SIRT1,影响FOXP3降解,调控Tri-Treg稳定性。本项目拟在细胞和动物模型等水平上观察分析IKZF2对Tri-Treg细胞中FOXP3乙酰化和稳定性的影响,并通过分析Akt1活化和SIRT1的核浆转运来明确IKZF2调控FOXP3和Tri-Treg稳定性的具体分子机制,为阐明银屑病等自身免疫性疾病的免疫紊乱机制奠定基础。
英文摘要
It has been identified that the overactivation of effector T cells due to the decreased function of CD4+CD25highFOXP3+Treg cells (Tri-Treg) plays important roles in psoriasis. Our previous study demonstrated that psoriatic Tri-Treg cells were not stable and they could transferred into effector T cells through mTORC2-Akt1 activation under streptococcus infections. Recent research found that IKZF2+ Tri-Treg cells showed strong stability with unknown mechanism. The deacetylase SIRT1 is involved in the regulation FOXP3 stability by its deacetylase activity through nucleus-cytoplasm translocation. Beased on previous results, we propose that IKZF2 regulates Tri-Treg stability by inflencing FOXP3 degradation through controling Akt1 activation and SIRT1 nucleus-cytoplasm translocation. In this project, we will observe and analyze IKZF2's effects on FOXP3 acetylation and stability in Tri-Treg cells on the levels of cells and animal modes. We will identify the detailed molecular mechanism by which IKZF2 regulates FOXP3 and Tri-Treg stability through analyzing Akt1 activation and SIRT1 nucleus-cytoplasm translocation. Our study will help to establish good foundation for the identification of immunological abnormality in autoimmne disorders like psoriasis.
CD4+CD25highFOXP3+Treg细胞(Tri-Treg)抑制功能下降,导致效应性T细胞过度活化是银屑病免疫学紊乱的重要环节。我们证明,银屑病中Tri-Treg细胞不稳定,在链球菌等感染下通过mTORC2-Akt1轴的活化可失去FOXP3,转变为效应性T细胞。同时发现,IKZF2+ Tri-Treg亚群稳定性强,但机制不清。去乙酰化酶SIRT1降低FOXP3乙酰化,通过核浆转运调控其稳定性。结合前期基础,我们提出IKZF2通过抑制Akt1亚型活化来调节SIRT1,影响FOXP3降解,调控Tri-Treg稳定性。本项目拟在细胞和动物模型等水平上观察分析IKZF2对Tri-Treg细胞中FOXP3乙酰化和稳定性的影响,并通过分析Akt1活化和SIRT1的核浆转运来明确IKZF2调控FOXP3和Tri-Treg稳定性的具体分子机制,为阐明银屑病等自身免疫性疾病的免疫紊乱机制奠定基础。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
The global profile of histone H3 acetylation and methylation is affected by FOXP3
组蛋白 H3 乙酰化和甲基化的整体特征受 FOXP3 影响
DOI:
--
发表时间:
2017
期刊:
Int J Clin Exp Med
影响因子:
--
作者:
[Liu W, Zhai Z, Chen L, Wang L, Zhang D, Ren W, Zhao Y, Shen Z]
通讯作者:
Shen Z
DOI:
10.1111/exd.12942
发表时间:
2016-07
期刊:
Experimental Dermatology
影响因子:
3.6
作者:
[Dongmei Zhang;Yanghong Chen;Ling Chen;Riyao Yang;Li Wang;Wenying Liu;Z. Zhai;Zhu Shen]
通讯作者:
Dongmei Zhang;Yanghong Chen;Ling Chen;Riyao Yang;Li Wang;Wenying Liu;Z. Zhai;Zhu Shen
LncRNA-AP4B1/SNRPA复合体通过调控PTPN22转录影响银屑病FoxP3+调节性T细胞的稳定性及机制研究
-
批准号:82073444
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2020
-
负责人:陈凌
-
依托单位:
rs3761548位点多态性对Foxp3在银屑病中转录的影响及分子机制的研究
-
批准号:30801013
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:陈凌
-
依托单位:
国内基金
海外基金